257 related articles for article (PubMed ID: 31785343)
21. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
22. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
23. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
24. Low-Value Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and the Association with Healthcare Utilization and Costs.
Duan KI; Spece LJ; Wong ES; Feemster LC; Donovan LM; Griffith MF; Keller TL; Bryant AD; Au DH
Ann Am Thorac Soc; 2021 Jun; 18(6):989-996. PubMed ID: 33290180
[No Abstract] [Full Text] [Related]
25. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
26. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.
Contoli M; Campo G; Pavasini R; Marchi I; Pauletti A; Balla C; Spanevello A; Ferrari R; Papi A
Eur J Intern Med; 2018 Jan; 47():82-86. PubMed ID: 28821412
[TBL] [Abstract][Full Text] [Related]
27. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
28. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
Morros R; Vedia C; Giner-Soriano M; Casellas A; Amado E; Baena JM;
Aten Primaria; 2019; 51(6):333-340. PubMed ID: 29661670
[TBL] [Abstract][Full Text] [Related]
29. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis.
Lee HW; Park J; Jo J; Jang EJ; Lee CH
PLoS Med; 2019 Nov; 16(11):e1002958. PubMed ID: 31730642
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD - subgroup analysis of the Taiwan obstructive lung disease cohort.
Wei YF; Kuo PH; Tsai YH; Tao CW; Cheng SL; Lee CH; Wu YK; Chen NH; Hsu WH; Hsu JY; Lin MS; Wang CC
Int J Chron Obstruct Pulmon Dis; 2015; 10():1951-6. PubMed ID: 26392770
[TBL] [Abstract][Full Text] [Related]
32. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
33. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
[TBL] [Abstract][Full Text] [Related]
34. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
Wilkie M; Finch S; Schembri S
COPD; 2015; 12(5):582-90. PubMed ID: 25774769
[TBL] [Abstract][Full Text] [Related]
35. Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice.
van den Bemt L; van den Nieuwenhof L; Rutjes A; van der Meer V; Stege G; Wensing M; Teichert M; Schermer T
NPJ Prim Care Respir Med; 2020 Oct; 30(1):43. PubMed ID: 33037200
[TBL] [Abstract][Full Text] [Related]
36. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
Pignatti P; Visca D; Zappa M; Zampogna E; Saderi L; Sotgiu G; Centis R; Migliori GB; Spanevello A
BMC Pulm Med; 2024 May; 24(1):247. PubMed ID: 38764008
[TBL] [Abstract][Full Text] [Related]
37. The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.
Belleudi V; Di Martino M; Cascini S; Kirchmayer U; Pistelli R; Formoso G; Fusco D; Davoli M; Agabiti N;
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1295-1304. PubMed ID: 27396695
[TBL] [Abstract][Full Text] [Related]
38. Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?
Rossi AP; Zanardi E; Zamboni M; Rossi A
Drugs Aging; 2015 Sep; 32(9):679-87. PubMed ID: 26297533
[TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids in COPD and the risk of lung cancer.
Lee YM; Kim SJ; Lee JH; Ha E
Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
[TBL] [Abstract][Full Text] [Related]
40. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
